211 top medical experts on Peroxisomal Disorders across 27 countries and 15 U.S. states, including 42 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Peroxisomal Disorders: A heterogeneous group of inherited metabolic disorders marked by absent or dysfunctional peroxisomes. Peroxisomal enzymatic abnormalities may be single or multiple. Biosynthetic peroxisomal pathways are compromised, including the ability to synthesize ether lipids and to oxidize long-chain fatty acid precursors. Diseases in this category include zellweger syndrome; infantile refsum disease; rhizomelic chondrodysplasia (chondrodysplasia punctata, rhizomelic); hyperpipecolic acidemia; neonatal adrenoleukodystrophy; and adrenoleukodystrophy (X-linked). Neurologic dysfunction is a prominent feature of most peroxisomal disorders.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Inborn Errors Metabolism (1,547) and Narrower Categories: Acatalasia (56), Adrenoleukodystrophy (1,753), Infantile Refsum Disease (44), Mevalonate Kinase Deficiency (688), Refsum Disease (141), Rhizomelic Chondrodysplasia Punctata (187), Zellweger Syndrome (501).
  4. Clinical Trials ClinicalTrials.gov : at least 10 including 5 Completed, 4 Recruiting
  5. Synonyms: Neonatal Adrenoleukodystrophy,  Hyperpipecolic Acidemia


  

        

                    


    Computing Expert Listing ...

);